Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro

British Journal of Cancer

Volumn 75, Issue 12, 1997, Pages 1744-1752

  Terzis, A J A ^a   Thorsen, F ^b   Heese, O ^a   Visted, T ^b   Bjerkvig, R ^b   Dahl, O ^b   Arnold, H ^a   Gundersen, G ^c  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF BERGEN   (Norway)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

Confocal microscopy; Cremophor EL; Glioma; Invasiveness; Paclitaxel (taxol); Three dimensional culture

Indexed keywords

ANTINEOPLASTIC AGENT; CREMOPHOR; PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONFOCAL MICROSCOPY; FLOW CYTOMETRY; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 0030918258     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.298     Document Type: Article

References (48)

1. Akslen LA, Andersen KJ and Bjerkvig R (1988) Characteristics of human and rat glioma cells grown in a defined medium. Anticancer Res 8: 797-804
2. Berkova N and Page M (1995) Addition of hTNF alpha potentiates cytotoxicity of taxol in human ovarian cancer lines. Anticancer Res 15 (3): 863-866
3. Bigner DD, Bigner SH, Ponten J, Westermark B, Mahaley MS, Ruoslahti E, Herschman H, Eng LF and Wikstrand CJ (1981) Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol 15: 201-227
4. Bjerkvig R (1986) Reaggregation of fetal rat brain cells in a stationary culture system. II: ultrastructure characterisation. In Vitro Cell Dev Biol 22: 193-200
5. Bjerkvig R (ed.) (1992) Spheroid Cultures in Cancer Research. CRP Press Inc.: Florida
6. Bjerkvig R, Laerum OD and Mella O (1986) Glioma cell interaction with fetal rat brain aggregates in vitro and with brain tissue in vivo. Cancer Res 46: 4071-4079
7. Bjerkvig R, Steinvaag SK and Laerum OD (1986) Reaggregation of fetal rat brain cells in a stationary culture system. I: methodology and cell identification. In Vitro Cell Dev Biol 22: 180-192
8. Cahan MA, Walter KA, Colvin OM and Brem H (1994) Cytotoxicity of taxol in vitro against human and rat malignant brain tumors. Cancer Chemother Pharmacol 33: 441-444
9. Carlsson J, Nilsson K, Westermark B, Ponten J, Sundström C, Carsson E, Bergh J, Pahlman S, Busch C and Collins VP (1983) Formation and growth of multicellular spheroids of human origin. Int J Cancer 31: 523-533
10. Chang AY, Kim K and Glick J (1993) Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: the Eastern Cooperative Oncology Group results. J Natl Cancer Inst 85: 388-394
11. Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson JS and Tsakuda Y (1983) Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 52: 997-1007
12. Chang YF, Li LL, Wu CW, Liu TY, Lul WY, Peng FK and Chi CW (1996) Paclitaxel induced apoptosis in human gastric carcinoma cell lines. Cancer 77: 14-18
13. Crossin KL and Carney DH (1981) Microtubule stabilization by Taxol inhibits initiation of DNA synthesis by thrombin and by epidermal growth factor. Cell 27: 341-350
14. Dugina VB, Alexandrova AY, Lane K, Bulanova E and Vasiliev JM (1995) The role of the microtubular system in the cell response to HGF/SF. Cell Sci 108: 1659-1667
15. Eorte Brain Tumour Group (1981) Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. J Neurosurg 55: 27-31
16. Gangemi RMR, Tiso M, Marchetti C, Severi AB and Fabbi M (1995) Taxol cytoxicity on human leukemia cell lines is a function of their susceptibility to programmed cell death. Cancer Chemother Pharmacol 36: 385-392
17. Glantz MJ, Choy H, Kearns CM, Mills PC, Wahlberg LU, Zuhowski EG, Calabresi P and Egorin MJ (1995) Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumours. J Natl Cancer Inst 87 (14): 1077-1081
18. Gundersen HJG and Jensen EB (1987) The efficiency of systematic sampling in stereology and its prediction. J Microscopy 147: 229-263
19. Heimans JJ, Vermorken JB, Wolbers FG, Eeltink JG, Meijer OW, Taphoorn MJ and Beijnen JH (1994) Paclitaxel (Taxol) concentrations in brain tumour tissue. Ann Oncol 5 (10): 951-953
20. Helson L, Helson C, Malik S, Ainsworth S and Mangiardi J (1993) A saturation threshold for taxol cytotoxicity in human glial and neuroblastoma cells. Anticancer Drugs 4: 487-490
21. Holmes FA, Frye D, Theriault RL, Walters RS, Forman AD, Newton LK, Buzdar AU and Hortobagy GN (1991) Phase II study of Taxol in patients with metastatic breast cancer. Proc Am Soc Clin Oncol 10: 60-63
22. Hruban RH, Yardley JH, Donehower RC and Boitnott JK (1989) Taxol toxicity. Epithelial necrosis in the gastrointestinal tract associated with polymerized microtubule accumulation and mitotic arrest. Cancer 63: 1944-1950
23. Jordan MA, Toso RJ, Thrower D and Wilson L (1993) Mechanisms of mitotic block and inhibition of cell proliferation by Taxol at low concentrations. Proc Natl Acad Sci USA 90: 9552-9556
24. Liebmann JE, Cook JA, Lipschultz C, Teague D, Fischer J and Mitchell JB (1993) Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines. Br J Cancer 68: 1104-1109
25. Lund-Johansen M, Engebraaten O, Bjerkvig R and Laerum OD (1990) Invasive glioma cells in tissue culture. Anticancer Res 10: 1135-1152
26. McGuire WP, Rowinsky EK, Rosenshein NB, Grumbine RC, Ettinger DS, Armstrong DK and Donehower RC (1989) Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 111: 273-279
27. Mueller-Klieser W (1987) Multicellular spheroids. A review on cellular aggregates in cancer research. J Cancer Res Clin Oncol 113: 101-122
28. Nygren P, Csoka K, Jonsson B, Fridborg H, Bergh J, Hagberg H, Glimelius B, Brodin O, Tholander B and Kreuger A (1995) The cytotoxic activity of Taxol in primary cultures of tumour cells from patients is partly mediated by Cremophor EL. Br J Cancer 71: 478-481
29. Otto AM and DE Assua LJ (1983) Microtubule-disrupting agents can independently affect the prereplicable period and the entry into S phase stimulated by prostaglandin F2 and fibroblastic growth factor. J Cell Physiol 115: 15-22
30. Riondel J, Jacrot M, Fessi H, Puisieux F and Potier F (1992) Effects of free and liposome-encapsulated taxol on two brain tumours xenografted into nude mice. In Vivo 6: 23-27
31. Rowinsky EK, Cazenave LA and Donehower RC (1990) Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst 82: 1247-1254
32. Schiff PB and Horwitz SB (1980) Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 77: 1561-1565
33. Schiff PB, Fant J and Horwitz SB (1979) Promotion of microtubule assembly in vitro by Taxol. Nature 277: 665-667
34. Silbergeld DL, Chicoine MR and Madsen CL (1995) In vitro assessment of taxol for human glioblastoma: chemosensitivity and cellular locomotion. Anticancer Drugs 6: 270-276
35. Sollott SJ, Cheng L, Pauly RR, Jenkins GM, Monticone RE, Kuzuya M, Froehlich JP, Crow MT, Lakatta EG and Rowinsky EK (1995) Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J Clin Invest 95: 1869-1876
36. Stearns ME and Wang M (1992) Taxol blocks processes essential for prostate tumour cell (PC-3 ML) invasion and matastases. Cancer Res 52: 3776-3881
37. 4 cells in vitro. Arch Gesschwulstforsch 51: 45-50
38. Stracke ML, Soroush M, Liotta LA and Schiffmann E (1993) Cytoskeletal agents inhibit motility and adherence of human tumour cells. Kidney Int 43: 151-157
39. Sutherland RM (1988) Cell and environment interactions in tumour microregions: the multicellular spheroid model. Science 240: 177-184
40. Sutherland RM, Freyer J and Mueller-Klieser W (1986) Cellular growth and metabolic adaptations to nutrient stress environments in tumour microregions. Int J Radiat Oncol Biol Phys 12: 611-615
41. Teng MH, Bartholomew JC and Bissel MJ (1977) Synergism between antimicrotubule agents and growth stimulants in enhancement of cell cycle traverse. Nature 268: 739-741
42. Tischler RB, Schiff PB, Geard CR and Hall EJ (1992) Taxol: a novel radiation sensitizer. Int J Radiat Oncol Biol Phys 22: 613-617
43. Trapp BD, Webster HD, Johnson D, Quarles RH, Cohen SR and Murray MR (1982) Myelin formation in rotation-mediated aggregating cell cultures: immunocytochemical, electron microscopic and biochemical observations. J Neurosci 2: 986-993
44. Verschueren H, Dewit J, De-Braekeleer J, Schirrmacher V and De-Baetselier P (1994) Motility and invasive potency of murine T-lymphoma cells: effect of microtubule inhibitors. Cell Biol Int 18: 11-19
45. 2/M arrest and apoptosis. Nature Med 2: 72-79
46. Walter KA, Cahan MA, Gur A, Tyler B, Hilton J, Colvin OM, Burger PC, Dump A and Brem H (1994) Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. Cancer Res 54: 2207-2212
47. Wani MC, Taylor HL, Wall ME, Coggon P and McPhail AT (1971) Plant antitumour agents. VI. The isolation and structure of Taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93: 2325-2327
48. Yuhas JM, Li AP, Martinez AO and Ladman AJ (1977) A simplified method for production and growth of multicellular spheroids. Cancer Res 37: 3639-3643